Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Vomiting 1Stomach Neoplasms 1Opioid-Related Disorders 1Nausea 1Hematologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Anorexia 1

Interventions

Dexamethasone 3naldemedine 1Palonosetron 1Olanzapine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nausea × Olanzapine × 90 days × Clear all
NCT07403370 2026-05-19

Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis

Shandong Cancer Hospital and Institute

Completed
2,000 enrolled

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡